Clonetics human cardiac fibroblasts from atrium and ventricle tissue

Friday, 04 February, 2011 | Supplied by: Lonza Australia Pty Ltd



Clonetics human cardiac fibroblasts from atrial and ventricular tissue are isolated from adult heart tissue and cryopreserved at passage 2 with 500,000 cells per vial.

Post-thaw expression of collagen is I 90% and Von Willebrand factor VIII 10%.

The fibroblasts are an important tool in the study of: cardiac cell function and interaction, myocardial repair and remodelling studies, patho-physiology (ie, hypertension and myocardial response to injury), extracellular maintenance during cardiac cell/tissue growth, cardiac fibrosis, paracrine signalling in heart disease, toxicology and cytotoxicity, and gene expression

The recommended media kit is the FGM-3 fibroblast growth media optimised for cardiac fibroblasts.

Online: www.lonza.com
Phone: 03 9550 0883
Related Products

AdipoGen Life Sciences tubulin products for neurodegeneration research

AdipoGen Life Sciences offers a broad range of microtubule research solutions. This includes...

SYnAbs monoclonal antibodies

SYnAbs produces innovative monoclonal antibodies against poor immunogenic compounds and complex...

Merck VirusExpress Lentiviral Production Platform

The platform helps to overcome lentiviral production challenges and can reduce process...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd